Clinical Trials Directory

Trials / Unknown

UnknownNCT04695262

EUS-Elastography and Contrast-Enhanced EUS Diagnostic Accuracy in the Differential Diagnosis of Subepithelial Gastrointestinal Tumors

EUS-Elastography and Contrast-Enhanced EUS Diagnostic Accuracy in the Differential Diagnosis of Subepithelial Gastrointestinal Tumors: a Multicenter Prospective Observational Study

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Istituto Clinico Humanitas · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers

Summary

The differentiation among the Gastrointestinal Subepithelial Tumors (SETs) represents a clinical challenge. Endoscopic Ultrasound (EUS) alone may be ineffective in differentiating SETs subtypes, and tissue sampling of these lesions may be technically difficult. EUS Elastography (EUS-E) has been applied to many gastrointestinal diseases, providing a qualitative/semi-quantitative stiffness analysis, but only few studies have examined the role of EUS-E in the diagnosis of SETs. In addition, the use of contrast agents has improved the diagnostic performance of the EUS, especially in the differentiation between GISTs and other gastrointestinal SETs. The aim of the study is to examine the performance of EUS-E and Contrast Enhanced-EUS (CE-EUS) in distinguishing among different gastrointestinal SETs subtypes. EUS patterns of different techniques will be compared to the final diagnosis gained by the analysis of histopatological specimens (surgical resection or EUS-FNB) or imaging/clinical follow-up.

Conditions

Interventions

TypeNameDescription
PROCEDUREEUS-FNBEndoscopic ultrasound (EUS)-guided fine needle biopsy (FNB)

Timeline

Start date
2021-01-27
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2021-01-05
Last updated
2023-03-21

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04695262. Inclusion in this directory is not an endorsement.